Hepatic cancer

Citations 11-20 of 256 total displayed.

Hepatology
Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysis

M A Silva, B Hegab, C Hyde, B Guo, J A C Buckels, and D F Mirza
Gut 2008 57: 1592 -1596; published online before print as 10.1136/gut.2008.149062 [Abstract] [Full text] [PDF] [Request Permissions]  

Hepatology
Hepatocellular carcinoma in Budd–Chiari syndrome: characteristics and risk factors

R Moucari, P-E Rautou, D Cazals-Hatem, A Geara, C Bureau, Y Consigny, C Francoz, M-H Denninger, V Vilgrain, J Belghiti, F Durand, D Valla, and A Plessier
Gut 2008 57: 828 -835; published online before print as 10.1136/gut.2007.139477 [Abstract] [Full text] [PDF] [Request Permissions]  

Hepatology
Pharmacological IKK2 inhibition blocks liver steatosis and initiation of non-alcoholic steatohepatitis

N Beraza, Y Malato, S Vander Borght, C Liedtke, H E Wasmuth, M Dreano, R de Vos, T Roskams, and C Trautwein
Gut 2008; 57: 655-663. [Abstract] [Full text] [PDF] [Request Permissions]  

Hepatology
Interferon decreases expression of human scavenger receptor class BI, a possible HCV receptor in hepatocytes

K Murao, H Imachi, X Yu, W M Cao, T Nishiuchi, K Chen, J Li, R A M Ahmed, N C W Wong, and T Ishida
Gut 2008 57: 664 -671; published online before print as 10.1136/gut.2006.111443 [Abstract] [Full text] [PDF] [Request Permissions]  

Hepatology
The novel gene MIA2 acts as a tumour suppressor in hepatocellular carcinoma

C Hellerbrand, T Amann, J Schlegel, P Wild, F Bataille, T Spruss, A Hartmann, and A-K Bosserhoff
Gut 2008 57: 243 -251; published online before print as 10.1136/gut.2007.129544 [Abstract] [Full text] [PDF] [Request Permissions]  

Liver disease
Long-term outcome of chronic hepatitis B in Caucasian patients: mortality after 25 years

G Fattovich, N Olivari, M Pasino, M D’Onofrio, E Martone, and F Donato
Gut 2008 57: 84 -90; published online before print as 10.1136/gut.2007.128496 [Abstract] [Full text] [PDF] [Request Permissions]  

Liver disease
Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma

Y-C Chou, M-W Yu, C-F Wu, S-Y Yang, C-L Lin, C-J Liu, W-L Shih, P-J Chen, Y-F Liaw, and C-J Chen
Gut 2008 57: 91 -97; published online before print as 10.1136/gut.2006.114066 [Abstract] [Full text] [PDF] [Request Permissions]  

Liver disease
Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels

M-F Yuen, Y Tanaka, N Shinkai, R T Poon, D Yiu-Kuen But, D Y-T Fong, J Fung, D Ka-Ho Wong, J Chi-Hang Yuen, M Mizokami, and C-L Lai
Gut 2008 57: 98 -102; published online before print as 10.1136/gut.2007.119859 [Abstract] [Full text] [PDF] [Request Permissions]  

Gut tutorials
Cholangiocarcinoma and its management

S A Khan, A Miras, M Pelling, and S D Taylor-Robinson
Gut 2007; 56: 1755-1756. [Extract] [Full text] [PDF] [Request Permissions] BMJ Learning: Take this module on BMJ Learning  

Colorectal cancer
Synergistic effects of RXR and PPAR ligands to inhibit growth in human colon cancer cells—phosphorylated RXR is a critical target for colon cancer management

Kenji Yamazaki, Masahito Shimizu, Masataka Okuno, Rie Matsushima-Nishiwaki, Nobuhiro Kanemura, Hiroshi Araki, Hisashi Tsurumi, Soichi Kojima, I Bernard Weinstein, and Hisataka Moriwaki
Gut 2007 56: 1557 -1563; published online before print as 10.1136/gut.2007.129858 [Abstract] [Full text] [PDF] [Request Permissions]